Skip to main content
OpenTrials
Completed

NCT Number: NCT02763241

Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis

The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution

Completed

Looking for future studies?

Notify Me

Key information

Age range

5 year and older

Sex eligibility

All sexes

Study type

Interventional

Phase

Phase 3

Primary location

Department of Otolaryngology, Khonkaen University

Muang, Khonkaen, 40002, Thailand

About this study

Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.

The nasal saline irrigation is the common procedure for upper respiratory tract infection patients including chronic rhinitis. The physician usually order the normal saline with appropriate medication e.g. anti-histamines, nasal steroids and anti-biotics to treat this condition.

The investigators proposed that the Cleanoze® is superior to the traditional nasal saline irrigation in term of the ease of use which will resulting in a better quality of life of the participants. This study will compared the efficacy, adverse reactions, complications and ease of use of Cleanoze® comparing with normal saline solution.

Study Population: Any patients with chronic rhinitis (e.g. allergic rhinitis, vasomotor rhinitis) will be randomized to receive the study or control medication. The investigators will include the children 5 years and above which able to doing the lavage under the parents assistant or by them self.

Study Design: Phase III randomized controlled trial

Sample Size: Estimate from pilot study, the 71 patients per arm was estimated (142 participants totally).

Study Duration:

  • Duration of enrollment is 1 year.
  • The patients will be followed up to 1 months depend on the disease conditions.
  • The data analysis will take 3 additional months
  • The full report will complete after the data analysis within 3 months
  • The total of 1 year and 6 months period needed for this study.

Primary Objective: To compare the satisfaction of the patients using Cleanoze® versus conventional device

Secondary Objective(s):

  • The adherence to Cleanoze® device
  • The durability of the Cleanoze® device
  • The patient symptom score (VAS)
  • The SNOT-22 questionaire for evaluating the quality of life of the patients

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Any patients with chronic rhinitis conditions regardless of any cause (e.g. allergic, irritant, infection)

Exclusion criteria

  • Acute or chronic rhinosinusitis
  • Acute nasopharyngitis (common cold)
  • Patients with a tendency to aspirate such as cerebrovascular accident, cranio-facial diseases.
  • Sinunasal, nasopharyngeal and skull base tumors
  • Age under 5 years old.
  • Cannot administer a saline irrigation under the assistant of a care giver.

Treatment and study plan

Cleanoze®

Drug

Cleanoze® consists of a powder made up of Sodium chloride and Sodium Bicarbonate. This powder when dissolved in 250 ml of water is closely resembles the content of a body fluid which normally baths the outside of the cells of the body. This fluid is isotonic solution.

Saline (Syringe irrigation)

Drug

Nasal irrigation using 250 ml normal saline pushing into the nostril by 20 ml syringe

Primary outcomes

  1. Satisfaction score

    Time frame: 1 month

    This score will be evaluated at the end of 1 month using using the satisfaction questionaire

Secondary outcomes

  1. The adherence to Cleanoze® devic

    Time frame: 1 month

    The adherence will be evaluated by the diary that the investigator given to the participants

  2. The durability of the Cleanoze® device

    Time frame: 1 month

    The durability will be evaluated by inspecting the device at the end of 1 month period

  3. The symptoms score of the patients

    Time frame: 1 month

    The symptoms score will be evaluated using the one-question VAS scale

  4. The Sino-Nasal Outcome Test-22 Questionnaire (SNOT-22) score

    Time frame: 1 month

    The SNOT-22 score will be evaluated by using SNOT-22 questionnaire

  5. Adverse events

    Time frame: 1 month

    The adverse events will be recorded in the case record form at follow-up time

Sponsors and collaborators

Lead sponsor

Khon Kaen University

Other

Collaborators

  • Farmaline Co.,Ltd., Thailand

Registry information

Official study title

Phase III Randomized Open-label Clinical Trial Comparing Cleanoze® Irrigation Device With Powder Preparation Versus Conventional Irrigation Method for Chronic Rhinitis

Important dates

Study start
2016
Primary completion
2018
Study completion
2018
First posted
May 5, 2016
Registry last updated
Aug 9, 2018

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Published trials that share one or more normalized conditions with this study.